Cas：612847-09-3
中文同义名：
英文同义名：
| 货号 | 纯度 | 规格/包装 | 货期 | 市场价 | 更新日期 |
|---|---|---|---|---|---|
| 品牌：Aladdin | |||||
| B304138-25mg | ≥97% | 25mg | 国内现货 | 936.90 | 2024-12-12 |
| B304138-5mg | ≥97% | 5mg | 国内现货 | 314.90 | 2024-12-12 |
| 品牌：罗恩 | |||||
| R052657-25mg | 1,3-二氢-1-[1-[4-(6-苯基-1H-咪唑并[4,5-g]喹喔啉-7-基)苯基甲基]-4-哌啶基]-2H-苯并咪唑-2-酮（AKT抑制剂VIII）,≥97% | 25mg | 国内现货 | 826.00 | 2024-11-13 |
| R052657-25mg | ≥97% | 25mg | 国内现货 | 871.00 | 2023-08-05 |
| 品牌：麦克林 | |||||
| B868586 | 1,3-二氢-1-[1-[4-(6-苯基-1H-咪唑并[4,5-g]喹喔啉-7-基)苯基甲基]-4-哌啶基]-2H-苯并咪唑-2-酮（AKT抑制剂VIII）,≥97% | 5mg | 国内现货 | 309.00 | 2024-12-12 |
| B868586 | 1,3-二氢-1-[1-[4-(6-苯基-1H-咪唑并[4,5-g]喹喔啉-7-基)苯基甲基]-4-哌啶基]-2H-苯并咪唑-2-酮（AKT抑制剂VIII）,≥97% | 25mg | 国内现货 | 918.00 | 2024-12-12 |
| 品牌：J&K | |||||
| 621993 | AKT inhibitor VIII, 98%, a cell-permeable quinoxaline compound that has been shown to potently 98% (J&K) | 10mg | 国内现货 | 658.00 | 2024-11-13 |
| 621993 | AKT inhibitor VIII, 98%, a cell-permeable quinoxaline compound that has been shown to potently 98% (J&K) | 5mg | 国内现货 | 362.00 | 2024-11-13 |
| 品牌：Meryer | |||||
| M55320 | 97% | 5mg | 国内现货 | 258.00 | 2023-11-15 |
| M55320 | 97% | 25mg | 国内现货 | 775.00 | 2023-11-15 |
| 品牌：源叶生物 | |||||
| S80837-5mg | 98%(HPLC) | 5mg | 国内现货 | 240.00 | 2024-11-13 |
| S80837-10mg | 98%(HPLC) | 10mg | 国内现货 | 400.00 | 2024-11-13 |
| 品牌：索莱宝Solarbio | |||||
| IA3060 | ≥98% | 5mg | 国内现货 | 1840.00 | 2024-11-29 |
| 品牌：Sigma-Aldrich | |||||
| 124018-1MG | ;Akt抑制剂VIII，同工酶选择性，Akti-1/2(Sigma-Aldrich) | 1mg | 国内现货 | 3542.47 | 2024-11-13 |
| 124018-5MG | ;Akt抑制剂VIII，同工酶选择性，Akti-1/2(Sigma-Aldrich) | 5mg | 国内现货 | 4168.98 | 2024-11-13 |
| 124018-1MG | ;Akt抑制剂VIII，同工酶选择性，Akti-1/2 | 1mg | 国内现货 | 3542.47 | 2024-11-26 |
| 124018-5MG | ;Akt抑制剂VIII，同工酶选择性，Akti-1/2 | 5mg | 国内现货 | 4168.98 | 2024-11-26 |
